Home>Topics>Companies>Biogen Idec

Biogen Idec

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
  1. Biogen Idec ( BIIB ) Q3 2014 Results - Earnings Call Webcast

    Headlines

    Wed, 22 Oct 2014

    Biogen Idec ( BIIB ) Q3 2014 Results - Earnings Call Webcast

  2. UPDATE 1- Biogen profit surges, but Tecfidera sales shy of Street view

    Headlines

    Wed, 22 Oct 2014

    Oct 22 (Reuters) - Biogen Idec Inc on Wednesday reported much higher-than-expected third-quarter profit and the company raised its full-year earnings forecast, even as its big-selling new oral...

  3. Biogen profit surges, but Tecfidera sales shy of Street view

    Headlines

    Wed, 22 Oct 2014

    Oct 22 (Reuters) - Biogen Idec Inc on Wednesday reported much higher third-quarter profit and revenue, even as its big-selling new oral multiple sclerosis drug Tecfidera fell short of lofty Wall...

  4. Determining Biogen's Fair Value

    Headlines

    Tue, 21 Oct 2014

    Determining Biogen 's Fair Value

  5. Forward Pharma's Threat To Biogen Idec's Tecfidera

    Headlines

    Mon, 20 Oct 2014

    Forward Pharma's Threat To Biogen Idec 's Tecfidera

  6. Biogen Idec Destroys Ecolab In 5 Games Of The Wild Card Round

    Headlines

    Mon, 6 Oct 2014

    we have #10 seeded Biogen Idec Inc . (NASDAQ: BIIB ) taking on #7 seeded ..... Inc. (NYSE: ECL ). Biogen is a biotechnology company ..... Revenue ($ in billions) BIIB 23Jul14 3.49 2.84 ..... 1.02 3.57 3.55 Biogen is up 36.12% in the

  7. Biogen to report on October 22

    Headlines

    Fri, 26 Sep 2014

    Biogen Idec ( BIIB +0.1% ) will report Q3 results before the open on October 22. The conference call will start at 9:00 am ET. Consensus view is EPS of $3.45 on revenues of $2.5B. Post your comment!

  8. Biogen Idec Offers Growth Investors An Attractive Entry Point

    Headlines

    Mon, 22 Sep 2014

    Asset Management and Research : Biogen Idec BIIB reported strong second quarter ..... revisions and growth estimates, Biogen Idec still offers investors strong upside potential. About The Company Biogen Idec discovers, develops, manufactures

  9. Why Biogen Stock Is Still An Investment Opportunity

    Headlines

    Sun, 21 Sep 2014

    By Arie Goren : Biogen Idec Inc . (NASDAQ: BIIB ) will continue to benefit ..... Nevertheless, in my opinion, BIIB 's stock still has room to move up. Biogen has decent valuation ..... margin. The Company Biogen Idec is one of the world's

  10. Celgene Looks Unstoppable

    Headlines

    Mon, 15 Sep 2014

    of large, powerful bio-pharmas. The others are Gilead (NASDAQ: GILD ), Regeneron (NASDAQ: REGN ) and Biogen Idec (NASDAQ: BIIB ). Management is deep and well-respected. Chairman / CEO Robert Hugin has executive experience within the

« Prev12345Next »
Content Partners